Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Invasive Urothelial Carcinoma – Post-Surgery Treatment

Medical Condition

Cancer

Facility/Clinic

PMG Research of DuPage Medical Group

Age

18 or older

Gender

Male/Female

Description

A research study is evaluating whether an investigational medication may lower the chances of the  bladder cancer to return in patients who have had surgery to remove invasive urothelial carcinoma.  

This research study may be an option if you: 
Have a diagnosis of invasive urothelial carcinoma 
Have FGFR3 Alterations 
Had nephroureterectomy, distal ureterectomy, or cystectomy within 120 days

Additional inclusion and exclusion criteria apply. Patients must meet all eligibility criteria to be considered for the clinical research study.
 
Qualified participants will receive study medication or placebo at no cost. You will not be required to pay for any study related procedures. You or your insurance company may be billed for any other health care costs, including those standard of care procedures that you receive while participating in the study. 

Enrollment

Open

Patient Commitment Duration

Dependent on disease status (such as recurrence

Patient Compensation

Financial compensation may be provided for travel expenses. 

Number of visits in study

Dependent on the length of participation in the study

Apply for this Study Now